Results 161 to 170 of about 315,758 (337)

Self-Care Behaviors in Insulin-Dependent Diabetes: Evaluative Tools and Their Associations with Glycemic Control [PDF]

open access: bronze, 1996
Cindy L. Hanson   +5 more
openalex   +1 more source

Gut Microbiota‐Bile Acid Metabolism Axis Drive Anti‐Diabetic Effects of Polygonatum cyrtonema Polysaccharide on Glycolipid Metabolism and Intestinal Inflammation

open access: yesFood Frontiers, EarlyView.
PCP‐80% could lessen the pathophysiology of T2DM in terms of controlling blood glucose/lipid levels and enhancing intestinal barrier function, via modulating the intricate web of intestinal microbiota/BAs/BAs signaling pathways. Red vertical arrows denote increases (HPCP‐80% vs. MC), blue vertical arrows indicate decreases (HPCP‐80% vs.
Xiaole Zhao   +8 more
wiley   +1 more source

Bioactive Compounds Derived From Natural Foods Against Metabolic Syndrome and the Advances of Resveratrol and Caffeic Acid in Microbial Cell Factory Production: A Review

open access: yesFood Frontiers, EarlyView.
Metabolic syndrome is characterized by abdominal obesity, hyperglycemia, dyslipidemia, and hypertension. Bioactive compounds extracted from herbs, tea, and coffee using microbial cell factories, particularly resveratrol and caffeic acid, have demonstrated remarkable potential in the management of metabolic syndrome, offering innovative solutions for ...
Tao Li   +7 more
wiley   +1 more source

The Australian paradox is confirmed: Updated evidence that refined sugars intake is declining

open access: yesJournal of Nutrition & Intermediary Metabolism, 2014
J.C. Brand-Miller, A.W. Barclay
doaj   +1 more source

Troglitazone Monotherapy Improves Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Randomized, Controlled Study1 [PDF]

open access: bronze, 1998
Vivian Fonseca   +4 more
openalex   +1 more source

Bioactive polysaccharides and their potential health benefits in reducing the risks of metabolic syndrome: A review

open access: yesFood Biomacromolecules, EarlyView.
Abstract Metabolic syndrome (MetS) is a complex noncommunicable condition characterized by central obesity, insulin resistance, hyperlipidemia, hypertension, and hyperglycemia. Epidemiological evidence shows that MetS affects a third of the global population; however, due to its complex pathogenesis and limited drug therapy options, the increasing ...
Josiah Owuor Oyalo   +3 more
wiley   +1 more source

Low glycemic index carbohydrate foods In the management of hyperlipidemia

open access: bronze, 1985
DJA Jenkins   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy